The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study.


Dinçbaş F., Oksüz D., Atalar B. , Altug T., Ilvan S., Gedik N., ...More

Medical oncology (Northwood, London, England), vol.26, pp.402-8, 2009 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26
  • Publication Date: 2009
  • Doi Number: 10.1007/s12032-008-9136-1
  • Title of Journal : Medical oncology (Northwood, London, England)
  • Page Numbers: pp.402-8
  • Keywords: Pelvic radiotherapy, Amifostine, Gemcitabine, Late normal tissue toxicity, ADVANCED PANCREATIC-CANCER, TWICE-WEEKLY GEMCITABINE, PHASE-I, RADIATION-THERAPY, CONCURRENT GEMCITABINE, RANDOMIZED-TRIAL, RECTAL-CANCER, WR-2721, CARCINOMA, TOXICITY